|
HNRNPL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.208400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.076400E-03 |
| Normal-vs-Stage2 |
7.757900E-03 |
| Normal-vs-Stage3 |
2.0162999999962E-05 |
| Normal-vs-Stage4 |
1.560980E-03 |
| Stage1-vs-Stage2 |
3.111400E-01 |
| Stage1-vs-Stage3 |
1.492280E-02 |
| Stage1-vs-Stage4 |
2.678800E-01 |
| Stage2-vs-Stage3 |
4.921200E-01 |
| Stage2-vs-Stage4 |
9.777400E-01 |
| Stage3-vs-Stage4 |
4.734800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.611900E-04 |
| Normal-vs-AfricanAmerican |
4.426000E-01 |
| Normal-vs-Asian |
4.885900E-02 |
| Caucasian-vs-AfricanAmerican |
2.025000E-01 |
| Caucasian-vs-Asian |
3.453200E-01 |
| AfricanAmerican-vs-Asian |
6.248800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.702120E-02 |
| Normal-vs-Female |
8.49950000000321E-05 |
| Male-vs-Female |
1.453220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.358700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.339100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.95120000001658E-06 |
| Normal-vs-Age(81-100Yrs) |
1.219020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.970800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.299300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.306000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.686300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.367000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.794600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.018900E-04 |
| Classical-VS-Follicular |
2.965600E-01 |
| Classical-VS-Other |
9.000400E-01 |
| Classical-VS-Normal |
1.017640E-02 |
| Tall-VS-Follicular |
4.701900E-02 |
| Tall-VS-Other |
8.323700E-02 |
| Tall-VS-Normal |
1.54949999997545E-06 |
| Follicular-VS-Other |
6.833000E-01 |
| Follicular-VS-Normal |
5.521300E-03 |
| Other-VS-Normal |
3.366600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.981100E-04 |
| Normal-vs-N1 |
2.752300E-04 |
| N0-vs-N1 |
3.152600E-01 |
|
|
